Critical reappraisal of short-acting bronchodilators for pediatric respiratory diseases

Ital J Pediatr. 2024 May 23;50(1):104. doi: 10.1186/s13052-024-01675-0.

Abstract

Short-acting bronchodilators are a class of medications commonly used to treat asthma, chronic obstructive pulmonary disease, and other respiratory conditions. The use of these medications has evolved over time as we have gained a better understanding of their effectiveness and safety in the pediatric population. This comprehensive review synthesizes the current understanding of short-acting β2-agonists and short-acting anticholinergics in children. It addresses indications, contraindications, safety considerations, and highlights areas where further research is needed to guide the most effective use of short-acting bronchodilators.

Keywords: Asthma; Bronchiolitis; Children; Short-acting bronchodilators; Wheezing.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • Asthma / drug therapy
  • Bronchodilator Agents* / therapeutic use
  • Child
  • Cholinergic Antagonists / therapeutic use
  • Humans
  • Pulmonary Disease, Chronic Obstructive / drug therapy

Substances

  • Bronchodilator Agents
  • Cholinergic Antagonists
  • Adrenergic beta-2 Receptor Agonists